{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:00:19Z","timestamp":1787032819850,"version":"build-2736575974"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,9]]},"DOI":"10.7759\/cureus.17033","type":"journal-article","created":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T12:58:31Z","timestamp":1628513911000},"source":"Crossref","is-referenced-by-count":1,"title":["Oral Valacyclovir Treatment of Herpes Zoster Ophthalmicus-Induced Optic Neuritis"],"prefix":"10.7759","author":[{"given":"Christina M","family":"Hunt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah M","family":"Gregory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Gannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2007.10.009","article-title":"Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity","volume":"115","author":"Liesegang TJ","year":"2008","unstructured":"Liesegang TJ. Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity. Ophthalmology. 2008, 115:S3-12. 10.1016\/j.ophtha.2007.10.009","journal-title":"Ophthalmology"},{"key":"ref2","article-title":"How to manage herpes zoster ophthalmicus","volume":"33","author":"Tuft S","year":"2020","unstructured":"Tuft S. How to manage herpes zoster ophthalmicus. Community Eye Health. 2020, 33:71-2.","journal-title":"Community Eye Health"},{"key":"ref3","article-title":"Evaluation and management of herpes zoster ophthalmicus","volume":"66","author":"Shaikh S","year":"2002","unstructured":"Shaikh S, Ta CN. Evaluation and management of herpes zoster ophthalmicus. Am Fam Physician. 2002, 66:1723-30.","journal-title":"Am Fam Physician"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa005","article-title":"Risk factors for herpes zoster infection: a meta-analysis","volume":"7","author":"Marra F","year":"2020","unstructured":"Marra F, Parhar K, Huang B, Vadlamudi N. Risk factors for herpes zoster infection: a meta-analysis. Open Forum Infect Dis. 2020, 7:ofaa005. 10.1093\/ofid\/ofaa005","journal-title":"Open Forum Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/jovr.jovr_65_17","article-title":"Herpes zoster ophthalmicus, central retinal artery occlusion, and neovascular glaucoma in an immunocompetent individual","volume":"14","author":"Ahmad SS","year":"2019","unstructured":"Ahmad SS, Suan AL, Alexander SM. Herpes zoster ophthalmicus, central retinal artery occlusion, and neovascular glaucoma in an immunocompetent individual. J Ophthalmic Vis Res. 2019, 14:97-100. 10.4103\/jovr.jovr_65_17","journal-title":"J Ophthalmic Vis Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8040547","article-title":"Does herpes zoster increase the risk of stroke and myocardial infarction? A comprehensive review","volume":"8","author":"Wu PH","year":"2019","unstructured":"Wu PH, Chuang YS, Lin YT. Does herpes zoster increase the risk of stroke and myocardial infarction? A comprehensive review. J Clin Med. 2019, 8:547. 10.3390\/jcm8040547","journal-title":"J Clin Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1212\/CON.0000000000000768","article-title":"Optic Neuritis","volume":"25","author":"Bennett JL","year":"2019","unstructured":"Bennett JL. Optic Neuritis. Continuum (Minneap Minn). 2019, 25:1236-64. 10.1212\/CON.0000000000000768","journal-title":"Continuum (Minneap Minn)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-018-1168-3","article-title":"Isolated optic neuritis with a concurrent abnormal trigeminal nucleus on imaging: case report of a rare complication of herpes zoster ophthalmicus","volume":"18","author":"Vanikieti K","year":"2018","unstructured":"Vanikieti K, Poonyathalang A, Jindahra P, Cheecharoen P, Patputtipong P, Padungkiatsagul T. Isolated optic neuritis with a concurrent abnormal trigeminal nucleus on imaging: case report of a rare complication of herpes zoster ophthalmicus. BMC Neurol. 2018, 18:165. 10.1186\/s12883-018-1168-3","journal-title":"BMC Neurol"},{"key":"ref9","unstructured":"Acyclovir. an overview. (2014). Accessed: May 5, 2021: https:\/\/www.uptodate.com\/contents\/acyclovir-an-overview."},{"key":"ref10","unstructured":"Treatment of herpes zoster in the immunocompetent host. (2014). Accessed. May 5, 2021: https:\/\/www.uptodate.com\/contents\/treatment-of-herpes-zoster-in-the-immunocompetent-host."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.7.1546","article-title":"Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults","volume":"39","author":"Beutner KR","year":"1995","unstructured":"Beutner KR, Friedman DJ, Forszpaniak C, Andersen PL, Wood MJ. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother. 1995, 39:1546-53. 10.1128\/AAC.39.7.1546","journal-title":"Antimicrob Agents Chemother"},{"key":"ref12","unstructured":"Valacyclovir. an overview. (2020). Accessed: March 31, 2021: https:\/\/www.uptodate.com\/contents\/valacyclovir-an-overview."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/00007435-199709000-00007","article-title":"Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection. Results of an international, multicenter, double-blind, randomized clinical trial. The Valaciclovir International Herpes Simplex Virus Study Group","volume":"24","author":"Fife KH","year":"1997","unstructured":"Fife KH, Barbarash RA, Rudolph T, Degregorio B, Roth R. Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection. Results of an international, multicenter, double-blind, randomized clinical trial. The Valaciclovir International Herpes Simplex Virus Study Group. Sex Transm Dis. 1997, 24:481-6. 10.1097\/00007435-199709000-00007","journal-title":"Sex Transm Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2018.07.002","article-title":"Acute kidney injury (AKI) associated with intravenous aciclovir in adults: incidence and risk factors in clinical practice","volume":"74","author":"Ryan L","year":"2018","unstructured":"Ryan L, Heed A, Foster J, Valappil M, Schmid ML, Duncan CJ. Acute kidney injury (AKI) associated with intravenous aciclovir in adults: incidence and risk factors in clinical practice. Int J Infect Dis. 2018, 74:97-9. 10.1016\/j.ijid.2018.07.002","journal-title":"Int J Infect Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2012-006264","article-title":"Acyclovir-induced acute renal failure and the importance of an expanding waist line","volume":"2012","author":"Seedat A","year":"2012","unstructured":"Seedat A, Winnett G. Acyclovir-induced acute renal failure and the importance of an expanding waist line. BMJ Case Rep. 2012, 2012:bcr2012006264. 10.1136\/bcr-2012-006264","journal-title":"BMJ Case Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1053\/bbmt.2002.v8.abbmt080662","article-title":"Oral valacyclovir versus intravenous acyclovir in preventing herpes simplex virus infections in autologous stem cell transplant recipients","volume":"8","author":"Liesveld JL","year":"2002","unstructured":"Liesveld JL, Abboud CN, Ifthikharuddin JJ, et al.. Oral valacyclovir versus intravenous acyclovir in preventing herpes simplex virus infections in autologous stem cell transplant recipients. Biol Blood Marrow Transplant. 2002, 8:662-5. 10.1053\/bbmt.2002.v8.abbmt080662","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198306163082404","article-title":"Acyclovir halts progression of herpes zoster in immunocompromised patients","volume":"308","author":"Balfour HH Jr","year":"1983","unstructured":"Balfour HH Jr, Bean B, Laskin OL, et al.. Acyclovir halts progression of herpes zoster in immunocompromised patients. N Engl J Med. 1983, 308:1448-53. 10.1056\/NEJM198306163082404","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1086\/586903","article-title":"Double-blind study comparing 2 dosages of valacyclovir hydrochloride for the treatment of uncomplicated herpes zoster in immunocompromised patients 18 years of age and older","volume":"197","author":"Arora A","year":"2008","unstructured":"Arora A, Mendoza N, Brantley J, Yates B, Dix L, Tyring S. Double-blind study comparing 2 dosages of valacyclovir hydrochloride for the treatment of uncomplicated herpes zoster in immunocompromised patients 18 years of age and older. J Infect Dis. 2008, 197:1289-95. 10.1086\/586903","journal-title":"J Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/63614-oral-valacyclovir-treatment-of-herpes-zoster-ophthalmicus-induced-optic-neuritis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T14:28:38Z","timestamp":1707488918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/63614-oral-valacyclovir-treatment-of-herpes-zoster-ophthalmicus-induced-optic-neuritis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,9]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.17033","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,9]]}}}